Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 29,194 shares at $41.59 ($1.2M) on 2021-04-07, disclosed to the SEC on 2021-04-08.
Open-market sale of $1.2M ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.95 | 10,000 | $410K | 33.9% |
| 2 | $41.59 | 9,194 | $382K | 31.6% |
| 3 | $41.59 | 9,194 | $382K | 31.6% |
| 4 | $42.34 | 806 | $34K | 2.8% |
| Total | $41.39 avg | 29,194 | $1.2M | 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |